ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,744.55
      -0.01%
      US Tech 100
      19,502.00
      -0.39%
      Dow Jones
      42,413.53
      0.57%
      Brent Oil
      71.515
      0.80%
      Bitcoin
      66,224.26
      1.60%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Argen X SE (ARGX) Quote

      Argen X SE

      Argen X SE (ARGX)

      argenx SE
      478.70
      2.10
      (0.44%)
      Closed September 27 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      478.70
      Bid
      478.00
      Ask
      484.70
      Volume
      42,334
      467.60 Day's Range 481.40
      271.00 52 Week Range 500.80
      Market Cap
      28.336B
      Previous Close
      476.60
      Open
      474.70
      Last Trade
      276
      @
      478.7
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      60,833
      Shares Outstanding
      59,194,000
      Dividend Yield
      -
      PE Ratio
      -105.45
      Earnings Per Share (EPS)
      -4.98
      Revenue
      1.27B
      Net Profit
      -295.05M

      About Argen X SE

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Coml Physical, Biologcl Resh
      Website
      www.argenx.com
      Headquarters
      Amsterdam, North Holland, Nld
      Founded
      -
      Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 476.60 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 500.80 €.

      Argen X currently has 59,194,000 shares outstanding. The market capitalization of Argen X is 28.21 € billion. Argen X has a price to earnings ratio (PE ratio) of -105.45.

      Ask ADVFN Intelligence (AI)

      ARGX Latest News

      More News

      argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

      ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

      September 19 2024
      GlobeNewswire Inc.

      argenx to Present at Upcoming Investor Conferences

      August 28, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

      August 28 2024
      GlobeNewswire Inc.

      argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

      $478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

      July 25 2024
      GlobeNewswire Inc.

      argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024

      July 18, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...

      July 18 2024
      GlobeNewswire Inc.

      argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

      First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in...

      July 16 2024
      GlobeNewswire Inc.

      argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

      ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of...

      June 25 2024
      GlobeNewswire Inc.

      argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

      VYVGART® Hytrulo is first and only neonatal Fc receptor (FcRn) blocker approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) First novel, precision mechanism of action in...

      June 21 2024
      GlobeNewswire Inc.

      argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024

      R&D Day presentations to include recent Phase 2 datasets in Sjogren’s disease (efgartigimod) and multifocal motor neuropathy (empasiprubart) that support advancement to Phase 3 development...

      June 17 2024
      GlobeNewswire Inc.

      argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference

      June 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...

      June 04 2024
      GlobeNewswire Inc.

      argenx Reports First Quarter 2024 Financial Results and Provides Business Update

      $398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in...

      May 09 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-3-0.622794270293481.7492456.392380479.48705694DE
      48.31.76445578231470.4500.8456.364846481.31420373DE
      1272.817.9354520818405.9500.8400.260833462.84354352DE
      26108.629.3434206971370.1500.8323.459217411.43833815DE
      5224.85.46375853712453.9500.827162875398.24377979DE
      156224.188.0204241948254.6500.8224.165571357.84857565DE
      260371.7347.38317757107500.893.0577731276.30392802DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AGILAgility Real Estate Inc
      $ 3.10
      (4,900.00%)
      		87
      DMSBSDiagnostic Medical Systems
      0.006 €
      (200.00%)
      		19.2k
      ALQGCQuantum Genomics
      0.0785 €
      (199.62%)
      		19.91M
      COBS3Casino Guichard Perrachon
      0.001 €
      (100.00%)
      		1M
      MLSUMSumo Resourcs Plc
      0.009 €
      (100.00%)
      		22.22k
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		11.31M
      ALREARealites
      2.00 €
      (-28.32%)
      		21.28k
      INAInapa Inv Part Gestao
      0.005 €
      (-26.47%)
      		14.66M
      ALNMRNamR SA
      0.954 €
      (-23.68%)
      		15.54k
      MLAATAzorean Tech
      0.25 €
      (-16.67%)
      		10.4k
      LOCALSolocal Groupe
      0.0028 €
      (-6.67%)
      		65.99M
      BCPBanco Comercial Portugues SA
      0.4087 €
      (-1.83%)
      		53.29M
      ALNEVNeovacs
      0.0006 €
      (0.00%)
      		21M
      ALQGCQuantum Genomics
      0.0785 €
      (199.62%)
      		19.91M
      PHARMPharming Group NV
      0.779 €
      (9.56%)
      		15.57M

      Discussion

      View Full Feed
      lager lager 15 seconds ago
      Nice movements today. Been offline.
      MGON
      Diamond_Dog Diamond_Dog 15 seconds ago
      There are a few motions in play from what I get out of the PACER Filing, I'm not a lawyer so my understanding is limited.

      Motion for Judgment Debtor Exam, MOTION for Protective Order, MOTION for Oral Argument, Motion for Hearing

      Motion day set for 10/17/2024 at 10:00
      facts_matter14 facts_matter14 33 seconds ago
      FUD or FACT? Down 99% since 2-12-21.

      FACT




      .
      SRMX
      longrider51 longrider51 36 seconds ago
      Name your state and we'll know with certainty that you again posted another blatant lie or are just simply unaware of the factual history. It is the objectively simple and factual truth that no state's residents and businesses were remotely or even possibly better of in 2020. Better in your twiste
      buylowsellhighcanada buylowsellhighcanada 39 seconds ago
      $MWRK - Stock to Watch
      Company name change and symbol change coming.
      Change of business direction.
      Volume bump, price correction.
      MWRK
      Captainandy Captainandy 57 seconds ago
      #JNUG: THE JUNIOR MINERS WILL DO BETTER THAN $JNUG GOING FORWARD...:-)
      JNUG
      Monksdream Monksdream 1 minute ago
      JKS a Chinese solar stock 10 day hourly
      https://investorshub.advfn.com/uimage/uploads/2024/9/27/nzbjgIMG_2185.gif
      Express1 Express1 1 minute ago
      Yes, 100%
      RITE
      zj3001 zj3001 1 minute ago
      Here we go. Flipper leader just loaded. Watch the pump!
      RNAZ
      ARZ ARZ 1 minute ago
      Lucky for you that you have only been around for 1 year. I have been around over 15 years. Bob Ferris gave alot less information and they did or even might still have a stock repurchase program which they never really took advantage of during the Ferris year. in a mater of fact they sold additional
      VTSI
      Prudent Capitalist Prudent Capitalist 2 minutes ago
      Yep. And, what is so amazing is that Trump bragged about how he created the Vaccine, and he was so proud of how fast they developed it. He was one of the first to receive it on TV and touted it hugely. It was all developed while he was still President, and I have to agree that it was a real down an
      LakeshoreLeo1953 LakeshoreLeo1953 2 minutes ago
      Mine is one of hope and timing
      NOT certainty and Soon.
      We all know the spokesperson for the later.
      AVXL
      bbee2 bbee2 2 minutes ago
      Rumor has it he is chauffeuring for Matthews. If Matthews requires a cold beverage, the “patient” one runs and gets it for him. If Matthews gets an urge for a box of Milkduds, or maybe a Meatball hero to remind him of his alias nicknames, the “patient“one is quick to accommodate. Yes, it is quite a
      GAHC
      The Man With No Name The Man With No Name 2 minutes ago
      So while your points above are factual

      Yes, now stop there before any foolish commentary.

      There is no way Treasury can cash out any time soon without a conversion of the SPS.
      FNMA
      mick mick 2 minutes ago
      encompassing the whole of a thing
      Holistic means encompassing the whole of a thing, and not just the part.
      Holistic medicine looks at the whole person for answers, not just at physical symptoms.
      You might have heard of holistic medicine, which tries to treat someone as mind an
      NASDAQ2020 NASDAQ2020 3 minutes ago
      I missed the news on Wednesday ?
      ELTP
      Dr Speculator Ninja Dr Speculator Ninja 3 minutes ago
      Most investors know and understand the stated product and development timelines in play. Anyone looking for immediate news is likely highly uninformed and can just move on. Could an unknown or expedited catalyst drop via PR? Absolutely. Coiled spring. Next move up will be another .10+ cents.
      ELTP
      LCJR LCJR 3 minutes ago
      Yep, financially sound decision right there. LOL Let’s pay $4.95 transaction fee for a .05 cent trade that won’t have any effect on the market.

      LCJR
      ASII
      Poo28 Poo28 4 minutes ago
      Shareholders are aware the disinformation continues despite being corrected , with facts. Experts are wrong, some say. Then refuse to be corrected ever? Want information not entitled as not required to be reported by the SEC. The relentless fictional nonsense , none of which is ever accurate. The
      DBMM
      uksausage uksausage 4 minutes ago
      great news, and hopefully indicated their desire for 100+ more next year when V 2.0 is available (and at a profit to NKLA)

      Should be getting the Q3 production numbers next week looking for well over 100 FCEV and hopefully most of the BEVs returned to customers or sold - tha may depend
      NKLA
      TradeForProfits TradeForProfits 4 minutes ago
      $GPOX #NYSE interview includes: recent expansion into Austin, San Antonio, and Houston. Stage set for over 1,000 store locations? Read more here: https://finance.yahoo.com/news/gpoplus-selected-interview-floor-nyse-110000208.html
      GPOX
      dexprs dexprs 4 minutes ago
      Added 400 MHO.

      Your Recent History

      EU
      ARGX
      Argen X
      Delayed Upgrade Clock